Clinical Trial Update: Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC [Phase 2]

View source ↗

Summary

Phase 2 study evaluating cetuximab with radiation therapy followed by consolidation chemotherapy in non-small cell lung cancer; trial results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: University of Pittsburgh | Conditions: Non Small Cell Lung Cancer (NSCLC) | Phase 2 | Status: COMPLETED | Results posted: 2017-02-01